Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
17-10-1|n/a,n/a|1|800|X-rays whole body|11.7|grays|External exposure local|upper body dogs aged 21-33 months|3 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|sacrifice 72-540 d after TBI, different hematological parameters including determinations of GM-CFC and BFU-E in the bone marrow and blood, bone marrow stromal progenitor cells (CFU-F) and colony-stimulating activity (CSA) in the serum; DNA damage in blood and bone marrow cells using the comet assay; sequential studies over 1.5 years after the exposure|No information on individuals available for this study
17-10-1|n/a,n/a|2|800|none (controls)||unit code not relevant|Injection, subcutaneously|carrier autologous serum for 7 days starting one day after exposure|3 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|sacrifice 72-540 d after TBI, different hematological parameters including determinations of GM-CFC and BFU-E in the bone marrow and blood, bone marrow stromal progenitor cells (CFU-F) and colony-stimulating activity (CSA) in the serum; DNA damage in blood and bone marrow cells using the comet assay; sequential studies over 1.5 years after the exposure|No information on individuals available for this study
17-10-2|n/a,n/a|1|800|X-rays whole body|11.7|grays|External exposure local|upper body dogs aged 21-33 months|3 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|sacrifice 540 d after TBI, different hematological parameters including determinations of GM-CFC and BFU-E in the bone marrow and blood, bone marrow stromal progenitor cells (CFU-F) and colony-stimulating activity (CSA) in the serum; DNA damage in blood and bone marrow cells using the comet assay; sequential studies over 1.5 years after the exposure|No information on individuals available for this study
17-10-2|n/a,n/a|2|800|colony stimulat. factor|30|milligrams per g animal|Injection, subcutaneously|rhG-CSF 30g/kg for 7 days starting one day after exposure|3 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|sacrifice 540 d after TBI, different hematological parameters including determinations of GM-CFC and BFU-E in the bone marrow and blood, bone marrow stromal progenitor cells (CFU-F) and colony-stimulating activity (CSA) in the serum; DNA damage in blood and bone marrow cells using the comet assay; sequential studies over 1.5 years after the exposure|No information on individuals available for this study
17-10-3|n/a,n/a|1|800|X-rays whole body|11.7|grays|External exposure local|upper body dogs aged 21-33 months|2 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|sacrifice 160-540 d after TBI, different hematological parameters including determinations of GM-CFC and BFU-E in the bone marrow and blood, bone marrow stromal progenitor cells (CFU-F) and colony-stimulating activity (CSA) in the serum; DNA damage in blood and bone marrow cells using the comet assay; sequential studies over 1.5 years after the exposure|No information on individuals available for this study
17-10-3|n/a,n/a|2|800|colony stimulat. factor|30|milligrams per g animal|Injection, subcutaneously|rhGM-CSF 30g/kg for 7 days starting 1 day after exposure|2 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|sacrifice 160-540 d after TBI, different hematological parameters including determinations of GM-CFC and BFU-E in the bone marrow and blood, bone marrow stromal progenitor cells (CFU-F) and colony-stimulating activity (CSA) in the serum; DNA damage in blood and bone marrow cells using the comet assay; sequential studies over 1.5 years after the exposure|No information on individuals available for this study
